Prognostic impact of pre-treatment and post-treatment plasma Epstein-Barr virus DNA in peripheral T-cell lymphomas
Plasma EBV DNA at diagnosis and during follow-up predict survival for NK/TCL patients but not for patients with other PTCL subtypes. Detection and monitoring of plasma EBV DNA levels at diagnosis and post-treatment follow-up for NK/TCL patients is recommended.
Authors
- Che‐Wei Ou
- Yi‐Jiun Su (ORCID: https://orcid.org/0000-0002-8372-1166)
- Hsiao‐Wen Kao (ORCID: https://orcid.org/0000-0002-3586-5317)
- Lee‐Yung Shih (ORCID: https://orcid.org/0000-0003-1866-7922)
- Yuen-Chin Ong (ORCID: https://orcid.org/0000-0003-2223-8661)
- Wen‐Yu Chuang (ORCID: https://orcid.org/0000-0002-3729-073X)
- Yu‐Shin Hung (ORCID: https://orcid.org/0000-0001-6976-5894)
- Hung Chang (ORCID: https://orcid.org/0000-0001-8451-0304)
- C.K. Chan (ORCID: https://orcid.org/0009-0009-6694-6265)
- Ming‐Chung Kuo
- Jin‐Hou Wu
- Tung‐Liang Lin (ORCID: https://orcid.org/0000-0002-9532-749X)
- Hsuan‐Jen Shih (ORCID: https://orcid.org/0009-0000-3877-2258)
Institutions
- Memorial Hospital of South Bend (US)
- Chang Gung University (TW)
- Chang Gung Memorial Hospital (TW)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2025-03-20
- DOI
- https://doi.org/10.1080/07853890.2025.2478315
- Citations
- 2
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.94
Funders
- Chang Gung Memorial Hospital